Provider Education Program for Opioid Use Disorder in Pregnant Women
(STEPuP Trial)

Recruiting in Palo Alto (17 mi)

Overseen byElizabeth Krans, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Pittsburgh

No Placebo Group

Trial Summary

What is the purpose of this trial?This research will test the effectiveness of a prenatal provider education and training program designed to facilitate provider adoption of evidence-based practices for the treatment of OUD during pregnancy. Findings from this research will provide high quality evidence about how to increase evidence-based treatment for pregnant women with OUD and subsequent maternal-child health outcomes.

Eligibility Criteria

This trial is for prenatal care providers who treat pregnant women with opioid use disorder (OUD). Providers must be English-speaking and work at obstetric sites. While patient data will be used, only a small group of English-speaking pregnant women meeting OUD criteria will be directly involved in interviews.

Inclusion Criteria

I speak English and can participate in a one-time interview.

I'm sorry, I need more information to understand the criterion. Can you please provide me with more context or the full criterion?

You are someone who takes care of pregnant women with opioid use disorder.

+1 more

Participant Groups

The STEPuP intervention is being tested against usual care to see if it improves the adoption of evidence-based treatments for OUD during pregnancy by prenatal providers. The goal is to enhance maternal-child health outcomes through better provider practices.

2Treatment groups

Experimental Treatment

Active Control

Group I: STEPuP InterventionExperimental Treatment1 Intervention

STEPuP interventions

Group II: Usual CareActive Control1 Intervention

Standard of Care